Madrigal MGL-3196-11: A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or
Research Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
Lucas Research, Inc.
Start Date
April 7, 2020
End Date
April 6, 2022
Administered By
Radiology, Abdominal Imaging
Awarded By
Lucas Research, Inc.
Start Date
April 7, 2020
End Date
April 6, 2022